DTC
JBIO

Deep Track Capital’s Jade Biosciences JBIO Stock Holding History

Deep Track Capital’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,279,892
Closed -$19.7M – 59
2025
Q3 		$19.7M Sell
2,279,892
-229,409
-9% -$1.87M 0.55% 35
2025
Q2 		$25.1M Buy
+2,509,301
New +$85.4M 0.8% 32

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $452M AUM
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

Deep Track Capital's JBIO Position: Q4 2025 in Review

Deep Track Capital sold out of Jade Biosciences (JBIO) in Q4 2025, closing a stake of 2,279,892 shares — an estimated $19.7M sold.

Deep Track Capital first reported a position in JBIO in Q2 2025 and held it in 2 quarters. The position peaked at $25.1M in Q2 2025. 105 funds tracked by Wall St. Rank hold JBIO as of Q4 2025.

  • Deep Track Capital reported no remaining Jade Biosciences position as of Q4 2025 after selling out during the quarter.
  • Deep Track Capital sold 2,279,892 Jade Biosciences shares in Q4 2025, an estimated $19.7M.
  • Deep Track Capital first reported a position in Jade Biosciences in Q2 2025 and held it in 2 quarters.
  • Deep Track Capital's Jade Biosciences position peaked at $25.1M in Q2 2025.
  • 105 funds tracked by Wall St. Rank held Jade Biosciences as of Q4 2025.

Based on Deep Track Capital's 13F filing for Q4 2025, filed 13 Feb 2026.